Update on Medical Developments: negative profit guidance, as expected (ASX:MVP)

Medical Developments (MVP) recently updated the market as to its operations and expected profits for FY13. As expected, net profit is expected to be down on 2012, by up to 15%. The market immediately reacted to this, and what followed was two days of savage selling… to a low of $1.06. Since then, the share […]